If tolerance is good and no concerning reactions occur, consider increasing to twice-daily application or moving to a 1 percent concentration
It is part of a class of medications called incretin mimetics, specifically a glucagon-like peptide-1 (GLP-1) receptor agonist
Susan Jebb, professor of diet and population health at the University of Oxford and adviser to ministers and the NHS on obesity, said: In summary, what weve shown in this particular piece of analysis is that weight regain after medication is common and is rapid
Dermatologist consultation helps assess realistic outcomes for your specific skin type
Semaglutides role in digestive health is multifaceted
While bloating alone rarely necessitates medication discontinuation, persistent severe symptoms warrant thorough evaluation to exclude serious pathology and optimize the treatment regimen